Financhill
Buy
65

CRM Quote, Financials, Valuation and Earnings

Last price:
$337.86
Seasonality move :
8.9%
Day range:
$331.14 - $346.45
52-week range:
$212.00 - $369.00
Dividend yield:
0.47%
P/E ratio:
56.52x
P/S ratio:
9.02x
P/B ratio:
5.62x
Volume:
14.7M
Avg. volume:
7.9M
1-year change:
32.05%
Market cap:
$328.9B
Revenue:
$34.9B
EPS (TTM):
$6.08

Earnings Data

Next earnings date for CRM
Feb 28
2025
Most recent earnings per share
$1.58
Missed by $0.87
(Dec 3/2024)
Consensus Estimate
$2.45
(Dec 3/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q1 $10B -- -- $2.61 --
12/03/2024 Q4 $9.3B $9.4B $1.58 $2.45 -$0.87
08/28/2024 Q3 $9.2B $9.3B $1.47 $2.36 -$0.89
05/29/2024 Q2 $9.1B $9.1B $1.56 $2.37 -$0.81
02/28/2024 Q1 $9.2B $9.3B $1.47 $2.27 -$0.80
11/29/2023 Q4 -- -- $1.25 $2.06 -$0.81
08/30/2023 Q3 -- -- $1.28 $1.90 -$0.62
05/31/2023 Q2 -- -- $0.20 $1.61 -$1.41
03/01/2023 Q1 -- -- -$0.10 $1.36 -$1.46
11/30/2022 Q4 -- -- $0.21 $1.22 -$1.01
08/24/2022 Q3 -- -- $0.07 $1.03 -$0.96
05/31/2022 Q2 -- -- $0.03 $0.94 -$0.91
03/01/2022 Q1 -- -- -$0.03 $0.75 -$0.78
11/30/2021 Q4 -- -- $0.47 $0.92 -$0.45
08/25/2021 Q3 -- -- $0.56 $0.93 -$0.37
05/27/2021 Q2 -- -- $0.50 $0.88 -$0.38
02/25/2021 Q1 -- -- $0.28 $0.75 -$0.47
12/01/2020 Q4 -- -- $1.15 $0.75 $0.40
08/25/2020 Q3 -- -- $2.85 $0.67 $2.18
05/28/2020 Q2 -- -- $0.11 $0.69 -$0.58
02/25/2020 Q1 -- -- -$0.28 $0.56 -$0.84
12/03/2019 Q4 -- -- -$0.12 $0.66 -$0.78
08/22/2019 Q3 -- -- $0.11 $0.47 -$0.36
06/04/2019 Q2 -- -- $0.49 $0.61 -$0.12
03/04/2019 Q1 -- -- $0.46 $0.55 -$0.09
11/27/2018 Q4 -- -- $0.13 -- --
08/29/2018 Q3 -- -- $0.39 -- --
05/29/2018 Q2 -- -- $0.46 -- --
02/28/2018 Q1 -- -- $0.09 -- --
11/21/2017 Q4 -- -- $0.14 -- --
08/22/2017 Q3 -- -- $0.06 -- --
05/18/2017 Q2 -- -- $0.00 -- --
02/28/2017 Q1 -- -- -$0.07 -- --
11/17/2016 Q4 -- -- -$0.05 -- --
08/29/2016 Q3 -- -- $0.33 -- --
05/18/2016 Q2 -- -- $0.06 -- --
02/25/2016 Q1 -- -- -$0.04 -- --
11/18/2015 Q4 -- -- -$0.04 -- --
08/20/2015 Q3 -- -- -$0.00 -- --
05/20/2015 Q2 -- -- $0.01 -- --
02/25/2015 Q1 -- -- -$0.10 -- --

Salesforce Earnings Questions

  • How Much did Salesforce Generate in Revenue Last Quarter?

    Salesforce reported $9.4B worth of top line sales in its most recent quarter.

  • Did Salesforce Beat Earnings Last Quarter?

    Salesforce announced earnings per share of $1.58 which represents a miss of analyst forecast a $2.45 per share.

  • Is Salesforce Profitable?

    Salesforce reported $7.3B that represents $7.61 per share over the last quarter.

  • What is the Analyst Consensus for Salesforce EPS Next Year?

    Salesforce's earnings are forecast to grow from $4.20 per share to $8.20 per share next year representing an increase of 138.97%.

  • When is Salesforce's Earnings Date?

    Salesforce's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 0.73% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.55% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock